ArticleFrontiers in oncology2021

Added Value of Systemic Inflammation Markers in Predicting Clinical Stage T1 Renal Cell Carcinoma Pathologically Upstaged to T3a.

Hailang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.